Phase 3 study to assess efficacy and safety of tocilizumab in GCA

• Research type

  Research Study

• Full title

  A phase III, multicentre, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of Tocilizumab in subjects with giant cell arteritis

• IRAS ID

  119822

• Contact name

  Bhaskar Dasgupta

• Contact email

  bhaskar.dasgupta@southend.nhs.uk

• Sponsor organisation

  F.Hoffmann-La Roche Ltd

• Eudract number

  2011-006022-25

• ISRCTN Number

  ISRCTN

• REC name

  London - Central Research Ethics Committee

• REC reference

  13/LO/0388

• Date of REC Opinion

  15 May 2013

• REC opinion

  Further Information Favourable Opinion